Rallybio Corporation
RLYB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $212 | $212 | $212 | $38 |
| % Growth | 0% | 0% | 457.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $30 |
| Gross Profit | $212 | $212 | $212 | $8 |
| % Margin | 100% | 100% | 100% | 21.1% |
| R&D Expenses | $4,143 | $6,074 | $5,725 | $7,355 |
| G&A Expenses | $2,994 | $4,195 | $4,157 | $4,261 |
| SG&A Expenses | $2,994 | $4,195 | $4,157 | $4,261 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $7,137 | $10,269 | $9,882 | $11,616 |
| Operating Income | -$6,925 | -$10,057 | -$9,670 | -$11,608 |
| % Margin | -3,266.5% | -4,743.9% | -4,561.3% | -30,547.4% |
| Other Income/Exp. Net | $22,941 | $354 | $231 | $564 |
| Pre-Tax Income | $16,016 | -$9,703 | -$9,439 | -$11,044 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $16,016 | -$9,703 | -$9,439 | -$11,044 |
| % Margin | 7,554.7% | -4,576.9% | -4,452.4% | -29,063.2% |
| EPS | 0.36 | -0.22 | -0.21 | -0.25 |
| % Growth | 263.6% | -4.8% | 16% | – |
| EPS Diluted | 0.36 | -0.22 | -0.21 | -0.25 |
| Weighted Avg Shares Out | 45,059 | 44,841 | 44,775 | 44,661 |
| Weighted Avg Shares Out Dil | 45,059 | 44,841 | 44,775 | 44,661 |
| Supplemental Information | – | – | – | – |
| Interest Income | $462 | $523 | $644 | $811 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $35 | $26 | $28 | $30 |
| EBITDA | $16,051 | -$10,031 | -$9,642 | -$11,578 |
| % Margin | 7,571.2% | -4,731.6% | -4,548.1% | -30,468.4% |